89 results on '"Cagliostro, B."'
Search Results
2. Driveline Infection in LVAD Patients: Effect of Era, Pump Type and Treatment Strategy
3. Infection-Related Morbidity with Continuous-Flow Left Ventricular Assist Systems: A Comprehensive Analysis of the Randomized MOMENTUM 3 Trial
4. Serum Cystatin C as a Predictor of Early Outcomes and Long-Term Mortality in Contemporary LVAD Patients
5. Pre-LVAD Blood-Borne Infection is a Harbinger of Poor Prognosis after LVAD Implantation
6. Prospective Validation of the First Endoscopic Management Algorithm for Gastrointestinal Bleeding in Patients with Left Ventricular Assist Devices
7. Presence of Left Atrial or Left Ventricular Thrombus at the Time of CF-LVAD Implantation is Associated with Increased Post-Operative Risk of Stroke or Death
8. Predictive Value of Mean Arterial Pressure Versus Systolic Blood Pressure and Visit-To-Visit Blood Pressure Variability for Stroke and Pump Thrombosis in HeartMate II Patients
9. An International Survey of LVAD Hygeine Practices
10. A Prospective Validation of the First Endoscopic Management Algorithm for Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices
11. Creatinine versus Cystatin C Based Equations for Estimation of Renal Function in Left Ventricular Assist Device Patients
12. Endoscopic Evaluation in Patients with CF-LVADs with Gastrointestinal Bleeding: Are We Ready for a Paradigm Shift to Improve Care?
13. The Short-to-Shield Phenomenon in Heartmate II Left Ventricular Assist Devices: A Single Center Experience
14. Prospective Evaluation of Urine Dipstick for Detection of Moderate and Severe Hemolysis in Outpatients on CF-LVAD Support
15. Usefulness of a Multipronged Strategy to Prevent Device Thrombosis in HeartMate II Left Ventricular Assist Devices
16. Aortic Root Thrombus Formation in Patients with Continuous-Flow Left Ventricular Assist Devices (CF-LVADs)
17. Aspirin Responsiveness Predicts Mucosal Bleeding Events in Patients with Continuous-Flow Left Ventricular Assist Devices
18. Red Cell Distribution Width (RDW) Predicts 90-Day Mortality in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients
19. Effect of Body Mass Index on Outcomes of Heart Transplant Candidates Supported by Continuous-Flow Left Ventricular Assist Devices (CF-LVADs)
20. Genotype-Guided Warfarin Dosing in Continuous-Flow Left-Ventricular Assist Device (CF-LVAD) Patients
21. Lactate Dehydrogenase Isoenzyme Monitoring in Patients with Continuous-Flow Left Ventricular Assist Devices (CF-LVADs)
22. Validity and Reliability of a Next Generation Non-Invasive Blood Pressure Monitor in Patients with Continuous-Flow Left Ventricular Assist Device
23. Warfarin Sensitive Patients Have Higher Risk of Gastrointestinal Bleeding and Device Thrombosis on Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Support
24. Incidence and Predictors of Left Ventricular Functional Recovery on Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Support
25. Discharge Lactate Dehydrogenase (LDH) Level Predicts Early Device Thrombosis in Patients with HEARTMATE II Left Ventricular Assist Devices: A Retrospective Cohort Analysis
26. (969) - Creatinine versus Cystatin C Based Equations for Estimation of Renal Function in Left Ventricular Assist Device Patients
27. (750) - An International Survey of LVAD Hygeine Practices
28. (388) - A Prospective Validation of the First Endoscopic Management Algorithm for Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices
29. (55) - Predictive Value of Mean Arterial Pressure Versus Systolic Blood Pressure and Visit-To-Visit Blood Pressure Variability for Stroke and Pump Thrombosis in HeartMate II Patients
30. Palliative Care Effectively Guides Transition to Inpatient Hospice, Home Hospice or Home Services for End-of-Life Care of LVAD Patients
31. Use of Phosphodiesterase 5 Inhibitors in Continuous-Flow Left Ventricular Assist Device Patients With Pulmonary: Hypertension: A Contemporary Analysis
32. VKORC1 Genotype Predicts Warfarin Dosing and INR Kinetics in Patients With Continuous-Flow Left Ventricular Assist Devices (CF-LVADs)
33. Driveline Infection Is Not Associated With Increased Risk of Thrombotic Events in CF-LVAD Patients
34. Discriminatory Performance of Simple Urine Dipstick for Detection of Significant Hemolysis in CF-LVAD Patients
35. (1308) - The Short-to-Shield Phenomenon in Heartmate II Left Ventricular Assist Devices: A Single Center Experience
36. (670) - Prospective Evaluation of Urine Dipstick for Detection of Moderate and Severe Hemolysis in Outpatients on CF-LVAD Support
37. Reduction of Drive Line Infection in Continuous Flow Assist Devices: Use of Standard Kit Including Silver Dressing and Anchoring Device
38. (596) - Palliative Care Effectively Guides Transition to Inpatient Hospice, Home Hospice or Home Services for End-of-Life Care of LVAD Patients
39. (523) - VKORC1 Genotype Predicts Warfarin Dosing and INR Kinetics in Patients With Continuous-Flow Left Ventricular Assist Devices (CF-LVADs)
40. (325) - Discriminatory Performance of Simple Urine Dipstick for Detection of Significant Hemolysis in CF-LVAD Patients
41. (287) - Use of Phosphodiesterase 5 Inhibitors in Continuous-Flow Left Ventricular Assist Device Patients With Pulmonary: Hypertension: A Contemporary Analysis
42. (51) - Driveline Infection Is Not Associated With Increased Risk of Thrombotic Events in CF-LVAD Patients
43. (263) - Reduction of Drive Line Infection in Continuous Flow Assist Devices: Use of Standard Kit Including Silver Dressing and Anchoring Device
44. (685) - Discharge Lactate Dehydrogenase (LDH) Level Predicts Early Device Thrombosis in Patients with HEARTMATE II Left Ventricular Assist Devices: A Retrospective Cohort Analysis.
45. (1058) - QRS Duration Predicts Outcomes Following Implantation of a Left Ventricular Assist Device.
46. (902) - Validity and Reliability of a Next Generation Non-Invasive Blood Pressure Monitor in Patients with Continuous-Flow Left Ventricular Assist Device.
47. (1072) - Incidence and Predictors of Left Ventricular Functional Recovery on Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Support.
48. (280) - Aspirin Responsiveness Predicts Mucosal Bleeding Events in Patients with Continuous-Flow Left Ventricular Assist Devices.
49. (182) - Genotype-Guided Warfarin Dosing in Continuous-Flow Left-Ventricular Assist Device (CF-LVAD) Patients.
50. (277) - Red Cell Distribution Width (RDW) Predicts 90-Day Mortality in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.